Stock Ratings / Financials / HQL / dividends

FTHY (59) TYG (60) ETO (59) NOAH (64) ⌘ Pro Terminal →

abrdn Life Sciences Investors (HQL) Dividend Safety Gauge & 10-Year DRIP Compounder

$18.74 +2.52% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $18.79

abrdn Life Sciences Investors (HQL) carries a Roarable Rating of D+ (Sell) with 56/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record: Scores of 56/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.4% avg 90D alpha vs SPY) →

ROARABLE D+ • SELL / AVOID Cap $481.2M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $18.79 (+0.26%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 11/20 (D+) • 0.3% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 56/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.4% avg 90D alpha vs SPY • 51.8% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D+

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D · Rk C

Each axis scored 0–20

12M PRICE TARGET CONE-0.9% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for HQL)Realized 20D OHLCV Swing Band: ±6.1%

Deterministic 5-Pillar Attribution (56/100 Composite)

🔍 WHY HQL SCORES 56/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (23% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▲ #2 Bullish Driver: Macro Regime Fit+13/20 pts (23% of score)

FRED Regime × Technicals: 44% of 52W Range • RSI-14 at 53 (NEUTRAL RANGE)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution9/20 pts (-11 pt drag)

Disciplined Float (-0.40% YoY Shares) & executive Form 4 sales trim 11 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade D$18.15-7.5% Next Q

Q2 (-2Q)

Grade C-$16.78+5.7% Next Q

Q3 (-1Q)

Grade C-$17.73+5.7% Next Q

Current

Grade D+$18.74-0.4% Hist 90D α

Trajectory: D (48) → D+ (56)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the HQL Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 56/100 (D+) score, HQL faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Company executives have done more routine share selling than personal cash buying lately.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Disciplined Float (-0.40% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($19.11) or 200D SMA ($18.24) invalidates the momentum regime and cuts Target Base ($18.57) toward Bear Floor ($14.48).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $HQL• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “HQL Beats Next Quarter EPS Consensus (Upcoming Quarter) & Holds Above 200D SMA”

YES 56%NO 44%Trade / Inspect Odds →

CASH DIVIDEND + BUYBACK YIELD

1.8% Total Yield

0% Cash ($0.00/yr) + 1.8% Buybacks

PAYOUT SAFETY SPEEDOMETER

74/100 • REINVESTING IN GROWTH + BUYBACKS

FREE CASH FLOW PAYOUT RATIO

0% (100% Reinvested)

Retains cash flow for R&D and share repurchases

INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (6.8% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $19,307

Est. Year-10 Shareholder Yield: $348/yr

Starting Investment: $10,000

Compounding Horizon: 10 Years

$10.7K

Yr 1

$11.4K

Yr 2

$12.2K

Yr 3

$13.0K

Yr 4

$13.9K

Yr 5

$14.8K

Yr 6

$15.8K

Yr 7

$16.9K

Yr 8

$18.1K

Yr 9

$19.3K

Yr 10

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring HQL)

✓Walkthrough of HQL's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

HQL // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +7.09%📐 HORIZONTAL RANGE

2026-10-30O $18.77H $18.77L $18.25C $18.74VOL 86.5K

RES: $25.13SUP: $16.16SMA50: $19.11SMA200: $18.24

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

HQL Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 HQL Butterfly Map → + Track HQL →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on HQL today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for HQL. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for HQL today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (HQL)

Financials Rank #680 of 1096 ⚔️ FTHY vs HQL Full Matrix →

1. Head-to-Head Financials Peer Comparison (HQL vs. FTHY, TYG, ETO, NOAH)

Industry: Investment Managers (79 Tracked Issuers)

Across 1096 tracked Financials securities in the Roarable RQD universe, abrdn Life Sciences Investors (HQL) ranks #680 by composite RQD confidence (56/100, grade D+) and #715 by equity capitalization ($481.2M). Within this direct 5-issuer industry benchmark cohort, NOAH leads on earnings valuation at 5.8x trailing P/E, while NOAH leads on capital efficiency and profitability with 11.2% ROIC and — gross margin. NOAH currently holds the highest overall quantitative score in the immediate peer group at 64/100 (C) compared with HQL at 56/100 (D+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
HQL ACTIVE abrdn Life Sciences Investors	D+	56/100	—	—	—	+2.52%	$481.2M	Benchmark Subject
FTHY First Trust High Yield Opportunities 2027 Term Fund	C-	59/100	—	—	—	+0.54%	$481.7M	/fthy-vs-hql →
TYG Tortoise Energy Infrastructure Corporation	C-	60/100	—	—	—	+4.15%	$479.0M	/tyg-vs-hql →
ETO Eaton Vance Tax-Advantage Global Dividend Opp	C-	59/100	—	—	—	+0.03%	$492.8M	/eto-vs-hql →
NOAH Noah Holdings Limited	C	64/100	5.8x	—	11.2%	0.00%	$462.0M	/noah-vs-hql →

2. HQL Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics

TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOT

abrdn Life Sciences Investors (HQL) operates in Investment Managers (Financials) with an equity capitalization of $481.2M, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.

3. HQL Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is HQL stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, abrdn Life Sciences Investors (NYSE: HQL) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 56/100 at a spot price of $18.74 (+2.52% 1D, market cap $481.2M). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 10/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 9/20. Across 1096 tracked Financials issuers, HQL ranks #680 in composite RQD confidence.

How does HQL compare to FTHY and TYG in the Financials sector?

Within the Financials sector (Investment Managers), HQL carries a Roarable D+ (56/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, FTHY (First Trust High Yield Opportunities 2027 Term Fund) holds a C- grade (59/100 RQD, P/E N/A, ROIC —, cap $481.7M) and TYG (Tortoise Energy Infrastructure Corporation) posts a C- grade (60/100 RQD, P/E N/A, ROIC —, cap $479.0M). Among the 5-stock peer group, NOAH leads on earnings multiple (5.8x) while NOAH leads on capital efficiency (11.2% ROIC).

What are the biggest fundamental strengths and SEC risk factors for HQL?

For abrdn Life Sciences Investors (HQL), key quantitative strengths include Established market leader in Financials with deep daily trading liquidity. and sector rank #680 in Financials, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and implied 5-year growth hurdle of 8.0%/yr. Institutional options positioning shows a 50% call / 50% put premium split.

Where is HQL trading relative to its 50-day, 200-day, and 52-week technical levels?

HQL last traded at $18.74 (+2.52% on volume of 102,871 shares), positioning the stock -1.94% below its 50-day simple moving average ($19.11) and +2.74% above its 200-day simple moving average ($18.24). Across its 52-week range of $15.66 to $22.67, HQL sits at the 43.9% percentile with a 14-day RSI of 53.0 (NEUTRAL RANGE) and an implied next-earnings move of ±6.1% ($17.60 to $19.88).

HQL Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Does HQL pay a dividend and is it safe?

abrdn Life Sciences Investors (HQL) offers a 0% cash dividend yield ($0.00 annualized) and 1.8% total shareholder yield including buybacks. Roarable rates its payout coverage as REINVESTING IN GROWTH + BUYBACKS.

Direct Sub-Reports: HQL RQD Cockpit HQL 12M Forecast HQL Earnings & Move HQL Dividends & DRIP HQL Insiders & 13F HQL Whale Options HQL Profit Sankey HQL News & Why